Fa'aletonu Tau Tupe: GenScript H1 2026 I'uga tautupe mo le Peptide CDMO Fa'agaioiga
Ina ia maua mai lesona fa'atino mo le au fai peptide laiti ma le vaeluagalemu, e tatau ona tatou vaʻavaʻai muamua i tua atu o faʻamaumauga tuʻufaʻatasia ma suʻesuʻe le faʻaogaina o fua faatatau i totonu o vaega o lipoti a GenScript.
|
Fuafuaga Tau Tupe
|
H1 2025 Fa'avae |
H1 2026 Fa'ailoa |
Fuafuaga o le YoY Shift |
Tulaga Fa'atino |
|---|---|---|---|---|
|
Tu'ufa'atasi Tupe Maua |
US$317.4M |
US$404.2M |
+27.3% |
Fa'aosoina e le mana'omia malosi i 'au'aunaga su'esu'e fa'asaienisi o le olaga ma le fa'asologa fa'asologa o AI. |
|
Life Science Group (LSG) Tupe maua |
US$247.6M |
US$319.0M |
+28.8% |
E atagia ai le fa'alauteleina o le gafatia o le fa'aogaina ma fa'autometi fa'aola galuega maualuga. |
|
LSG Fetuuna'i Tupe Fa'asili |
~51.0% |
57.8% (55.4% totogi muamua) |
+440 ia +680 bps |
Ole fa'aoga maualuga ole fa'aogaina fa'atasi ma le fa'afefiloi o auaunaga fa'apitoa e fa'afeiloa'i ile fa'asologa lavelave. |
|
LSG Fetuuna'i Tupe Fa'atino |
US$46.4M |
US$94.0M |
+102.8% |
O le tau fa'agaioiga e pei o tau fa'amautu sa fa'asoa atu i vaega tetele. |
|
ProBio CDMO Tupe maua |
US$45.5M |
US$61.1M |
+34.2% |
Fa'alauteleina i konekarate fa'ato'a fa'ata'ita'i fa'aa'oa'oga ma atina'e faiga. |
|
Vaega R&D Tupe alu |
US$30.46M |
US$38.16M |
+25.3% |
Toe fa'aagaga o le ~ 9.4% o tupe maua i totonu ole masini fa'apipi'i AI ma le fa'aogaina o le vai. |
|
Tupe Fa'aalu (Capex) |
— |
US$48.4M (H1) |
~$130M FY26 Fuafuaga |
Fa'atumauina fa'aagaga i le fa'alautelega o potu mama ma fa'aputuga maualuga HPLC tapenapenaga. |
Fa'amaumauga na tu'ufa'atasia mai le GenScript's HKEX faila le tumau tau tupe.
Fa'asologa o le Peptide O le faailo sili ona mataʻina i lenei taʻavale o le 102.8% fa'ateleina tupe mama fa'atino mo le Life Science Group i luga o a 28.8% tupe maua pito i luga. O lo'o fa'ailoa mai ai o le taimi lava e laasia ai e se fa'aupuga fa'aopoopo le fa'amatalaga o le fa'aogaina o aseta tumau, fa'aopoopo tupe maua e tafe sa'o i le laina pito i lalo.
Lesona Faagaioiina #1: Aveina Fa'asiga Fa'asilasito E ala i le fa'aogaina otometi ma fa'afefiloi maualuga-taua
Ausia se fetuutuunai tupe faasili i luga 55% i le peptide masani ma le gaosiga o le soifua maloloina e manaʻomia le faʻaeteete o le faʻatonutonuina o faʻalavelave faʻagaioia e lua: fe'avea'i tau o mea mata'utia ma fua fa'aletonu ole fa'asologa.
1. Otometi Maua'i Maualuga vs. Fa'atasiga Tusia
Fa'asologa o le peptide fa'asolosolo fa'atasi (SPSS) fa'alagolago tele i le taumafaina o le solvent (DMF, NMP, DCM), amino acids puipuia (Fmoc/tBu), ma so'o fa'atasi (LAASAGA, HBTU, DIC/Oxyma). I fa'agaioiga tusita'avale po'o semi-automated, fa'aputu fa'aputu fa'aputu vave ma fa'atuai fa'atasi, fa'alaloina le mama mama ma fa'atuputeleina le HPLC fa'asolosolo fa'asolosolo (sauniuni-HPLC) taamilosaga o le faamamaina.
O le faʻalauteleina o laina ole GenScript e faʻaalia ai le aʻafiaga o le faʻaogaina otometi, microwave fa'aparale ma fa'atūlaga fa'asolosolo fa'asolosolo. E ala i le fa'avasegaina o le vevela o le tali ma le fua fa'aautometi o le vai:
-
Fa'ateleina le fa'aogaina o le resini, fa'aitiitia fa'amatalaga le mama peptide.
-
Solvents ma reagents e fuaina i le sili atu stoichiometric sili atu, tipiina otaota mea mata e 15% ia 25%.
-
Fa'amama fa'amama fa'ama'i ua fa'aitiitia, ona o le mama mama maualuga e mafai ai ona faʻalauteleina faʻamalama faʻamalama i luga o koluma prep-HPLC.
2. Siitia Au'aunaga Fa'afefiloi I Suiga Lavelave
Peptides laina masani (lalo 20 amino acids) pagatia i tau fa'atauva'a ma fa'aitiitiga tau. I ata vaaia, O le faʻalauteleina o le laina ole GenScript na faʻamalosia e se suiga faʻafefiloi maaleale agai i luga-maualuga, fa'atonuga fa'apitoa:
-
Fatty Acid Conjugation & Lipidation: Palmitoylation ma filifili acid di-ga'o (C16, C18, C20) manaʻomia mo le faʻalauteleina o le afa o le ola ile GLP-1/GIP multi-agonist development.
-
Ta'amilosaga & Stapling: Ulu-i-si'u, alalaupapa lactam, ma le faia o mama multi-disulfide.
-
Fale Isotope & Fa'ailoga Fa'alila: Biotinylation, FITC, Cy-faasologa, ma le NMR/MS fa'avasegaina tulaga fa'atatau.
Mo tagata tu'ufa'atasi tulagalua, ofoina fa'apitoa 'au'aunaga tu'ufa'atasiga o le peptide fa'atasi ai ma fa'aputuga fa'aopoopo (pei o le 300+ suiga fa'atinoga ma ala SPPS/fa'apalua lua) tatala fa'ailoga tau fa'apitoa e puipuia ai le pisinisi mai le fa'atauina.
Lesona Faagaioiina #2: Fa'apaleni le Fa'aogaina o le Gafatia e Fa'asaga i le Gaosia Fetuuna'i
O le fa'aogaina o le agava'a o le tasi lea fa'amauina sili o tupe maua a le CDMO, ae o le soona fa'aogaina e fa'ailoa mai ai ni fa'alavelave matuia fa'atino.
E tusa ai ma le maketi atamai i US peptide CDMO agava'a fa'aogaina fa'ailoga, faatuina US peptide CDMO fale faagaoioia i 78% ia 85% fa'aogaina i le ogatotonu o le 2026. O le malamalama i le mea e pa'u ai se fale i luga o lenei fa'aoga fa'aoga e iloa ai le aofa'i o tupe mama ma taimi e ta'ita'i ai tagata fa'atau:
Fa'aaogāga < 70% → Maualuluga Fa'amau Fa'aulu → Fa'amau Fa'amau
Fa'aaogāga 78-85% → Fa'atauga sili ona lelei + Fa'atonuga Fa'atino (Sone Soifua Maloloina)
Fa'aaogāga > 90% → Fa'agogo Meafaigaluega → Fa'atuai Fa'atau & Tulaga lelei
-
Lalo 70% Fa'aaogāga: Fale tumau i luga (potu mama HVAC, Mata'ituina le faamamaina o le HEPA, fa'aitiitiga o meafaigaluega su'esu'e, fa'amautinoaga lelei ole siosiomaga) taofiofi tupe faasili i lalo 30%.
-
78% ia 85% Fa'aaogāga (Le Su'esu'ega Lelei): O luga o le ulu ua fa'amauina o lo'o a'afia atoa i fa'agaioiga fa'agaioiga, ao 15% ia 22% o lo'o tatala pea le pa'u gafatia. E taua tele lenei pa'u mo le fa'afoeina o fa'alavelave toe fa'atupu fa'alavelave, tausiga o meafaigaluega, ma fa'anatinati talosaga fa'afuafua fa'afuafua e aunoa ma le fa'alavelaveina o taimi fa'atulagaina o tagata o tausia.
-
Luga 90% Fa'aaogāga: A'o maualuga tupe maua i luga ole laiga mo sina taimi, fa'atupu fe'ese'esea'i fa'atuputeleina. O koluma Prep-HPLC ua avea ma fa'amau, lyophilization potu avanoa fa'atapula'a le fa'auluina o vaega, ma fa'atuai le tausiga e ono afaina ai vaega po'o le gau o fua.
E tatau ona teena e le vaega ogatotonu o le CDMO le fa'aosoosoga e tusi le gafatia o fale 100%. Fa'atumauina se fa'atulagaina 15% fa'apolopolo fa'agaioiga puipuia le fa'atuatuaina o le tu'uina atu a'o fa'asaoina tupe fa'asili.
Lesona Faagaioiina #3: Fuafuaga R&D ma Capex Fefa'ataua'iga i le Peptide Gaosi
GenScript faasoasoa US$38.16 miliona ia R&D ile H1 2026 (~9.4% o le aofa'i o tupe maua a vaega) fa'atasi ma **US$48.4 miliona ile H1 tupe fa'aalu** (ua fuafua e o'o atu i le ~US$130 miliona mo le FY2026). O lenei fuafuaga fa'avae o lo'o fa'amamafaina ai se vaeluaga o pisinisi:
-
Otometi & Tu'ufa'atasiga fa'atekinolosi: Teu fa'afaigaluega i fa'asologa fa'asologa fa'asologa o AI e va'ai fa'alavelave fa'alavelave, aggregation propensity, ma le gaugau hydrophobic a'o le'i faia. O lenei su'esu'ega a'o le'i faia fa'aupuga e fa'aitiitia ai taumafaiga fa'apipi'i le manuia i le synthesizer.
-
Atina'e tetele & Fa'alautelega Potu Mama: Fa'afuafuaina ta'amilosaga koluma HPLC sauniuni, mea faigaluega cleavage faifai pea, ma su'ega afifiina mama.
Mo se peptide CRO poʻo CDMO ogatotonu, o le fa'afetauiina o se tala fa'atatau o tupe fa'aalu selau miliona tala e le mafai pe mana'omia. Nai lo lena, fa'ata'ita'i ta'ita'i vaeluagalemu fa'atatau i tupe fa'aalu:
-
Fa'aleleia le lyophilization ma le afifiina o siosiomaga e fa'amaonia Vasega 100 potu mama mama e fetaui ma le endotoxin malosi (<0.01 EU/mg) ma mea e mana'omia mo le aganu'u sela ma fa'aoga fa'apitoa.
-
Fa'atuina o paipa su'esu'e fa'ata'ita'i fa'avavevave (HPLC-MS, counterion TFA su'esu'ega fa'afesuia'i, su'esu'ega ole amino acid) e tu'uina atu Tusi Fa'amaonia o Su'esu'ega (COA) fa'atasi ma vaega fa'amama ma fa'amama.
-
O le taula'i atu o tupe faavae i le agile batch scale-up gafatia (mai le milligram screening i le tele-kilogram pailate vaega) nai lo laina API oloa mega-fua.
Se Ta'iala Fa'ata'ita'i Fa'ata'ita'i mo CDMO Peptide Mid-Tier & CROs
Ina ia fesoasoani i vaega fa'agaioiga a le CDMO ma le su'esu'eina o le biopharma e ta'ita'ia le iloiloga o le soifua maloloina, ua matou fa'avasegaina fa'ailoga fa'agaioiga a le GenScript i fua fa'atatau fa'atusatusaga e fa.
Mo Fautuaga: Fa'ata'atia au fa'agaioiga gaosiga e fa'atatau i fua fa'atatau nei e fa i kuata ta'i kuata e fa'ailoa mai ai fa'ama'i fa'ato'aga ma fa'agasolo tau a'o le'i a'afia tupe fa'aletausaga..
metric 1: Fuafuaga o le Fa'aaogāga o le potu mama (CCUR)
Fuaina le lelei o le fa'agaioiga o su'ega fa'agaioiga ma sone afifiina aseptic:
CCUR (%) = (Actual Operating Hours of Active Synthesis & Cleanroom Suites / Total Available Maintenance-Adjusted Hours) × 100
-
Fa'ailoga Fa'atatau: 78% – 82%
-
Fa'ata'ita'iga: Afai e pa'ū le CCUR i lalo 70%, toe fa'avasega taumafaiga tau atina'e pisinisi agai i tu ma aga maualuga Peptides fa'aola suiga; pe afai e sili atu le CCUR 88%, fa'alautele le gafatia muamua o le fa'amamāina o HPLC e puipuia ai le tafeta'i-taimi.
metric 2: Au'aunaga Mix Faasino Upu (SMI)
Fa'amauina le fa'atatau o galuega fa'alelei/fa'amama fa'atatau ile fa'asologa o laina masani.:
SMI (%) = (Revenue from Complex Modified, Cyclic, Isotope, Lipidated & Sterile Batches / Total Peptide Revenue) × 100
-
Fa'ailoga Fa'atatau: > 45%
-
Fa'ata'ita'iga: Fale e iai le SMI i lalo 30% o lo'o matua fa'aalia i le fa'aleagaina o tau mai le tau taugofie fa'aitulagi.
metric 3: Ma'ale'ale Tupe Fa'atasi vs. Fua Fa'atasi (GMSY)
Su'e pe fa'afefea ona a'afia sa'o ai tupe fa'asili i luga o fa'atonuga faigata: Gaosiga Peptide
GMSY = Gross Margin Change (%) / First-Pass Crude Purity Change (%)
-
Fa'ailoga Fa'atatau: 1.2 ia 1.8
-
Fa'ata'ita'iga: O se fua faatatau maualuga maaleale e faailoa mai ai le tau o meafaitino (amino acids ma so'o fa'atasi) o lo'o 'ai i tupe mama ona o le le manuia o le toe fa'aopoopoina. O le fa'aaogaina o cocktails cleavage sili ona lelei ma le fa'aogaina o le vevela e fa'aitiitia ai lenei lagona.
metric 4: R&D Reinvestment Intensity Ratio (RDIR)
Iloilo pe o toe fa'atupe e le CDMO ni tupe fa'asili i le fa'atinoina o le fa'atonuga ma le fa'atonuga lelei:
RDIR (%) = (Internal Process Development & QC Automation Spend / Annual Revenue) × 100
-
Fa'ailoga Fa'atatau: 6.0% – 10.0%
-
Fa'ata'ita'iga: GenScript's ~9.4% fa'asoasoaina o lo'o fa'aalia ai o le fa'aauauina o le ta'ita'iga o maketi e mana'omia ai le fa'aauauina o tupe fa'aalu i le fa'agasologa o le malosi tele. (PMI) fa'aitiitiga ma fa'amaonia au'ili'ili.
Ta'iala mo Su'esu'ega mo Biopharma R&D Fa'ai'uga
Mo biopharma R&D faatonu, PIs, ma fa'atauga ta'ita'i, GenScript H1 2026 fa'atinoga fa'amalosia e le tatau ona fa'avae le filifiliga a le au fa'atau i luga ole fua pito i luga. A'o sili atu le maualuga o le CDMO i le gaosiga o oloa maualuga, e masani ona latou fa'alauiloa fa'asologa o taimi ta'imua ma le fa'atonuina o le fa'atonuga o galuega fa'atino mo galuega su'esu'e tu ma aga amata.
Biopharma Sourcing Decision Matrix
Fa'atauga Fa'atauga Mega-Fula (100kilokalama +) Mega-Scale CDMOs (Bachem, Lonza) • Taimi umi e ta'ita'ia • Tulaga maualuga MOQ • Fa'atonuga ma'a'a
Laasaga-Amata R&D ile Preclinical Pilot Agile Mid-Tier CDMOs (MOL Suiga) • Saosaoa suiga • Fa'atonu saienitisi Q&A • 300+ Suiga
Pe a iloiloina paaga peptide mo suʻesuʻega faʻapitoa, ta'ita'i optimization, po'o su'esu'ega fa'a-IND, E tatau i ta'ita'i o le biopharma ona fa'aoga lenei lisi o su'esu'ega a tagata fa'atau:
-
Fa'amatalaga manino & Fa'auma Fa'amaumauga: E tu'uina atu e le tagata fa'atau oloa ni chromatograms uma o le HPLC ma le Mass Spectrometry (MS) fa'amaoniga mo vaega ta'itasi, nai lo faamatalaga otooto?
-
Fa'amama & Endotoxin Fa'aitiitiga Tulaga lamatia: O fa'atasi, vaeluaga, ma lyophilization faia i totonu o siosiomaga potu mama faamaonia (Vasega ISO 5 / Vasega 100) ina ia mautinoa le maualalo o le endotoxin mo suʻega faʻavae i le sela ma faʻataʻitaʻiga in vivo?
-
Feso'ota'iga Auala Fegalegaleai: E iai ea i le CDMO ni agava'a lua i le SPPS, fa'atasiga vai-vaega (LPPS), ma microbial fermentation e lagolago ai le si'isi'i lelei mai le milligrams i le kilokalama?
-
Galulue Fa'ainisinia Tu'usa'o: E mafai e lau R&E feso'ota'i sa'o le vaega D ma foma'i peptide sinia e fo'ia fa'asologa o le hydrophobic, mataupu solubility, ma le fesuiaiga o le TFA?
Sponsors saili vave suiga, avanoa fa'atekinisi tuusa'o, ma fa'ainisinia fa'asologa fa'apitoa e manuia mai le faipaaga ma se fa'atosina agile peptide CDMO tulaga.
Fa'ai'uga & Fuafuaga Fa'ata'atia
GenScript's Q2/H1 2026 fa'ai'uga e fa'amaonia ai o le malosi o le fa'atinoga o tupe i le vaega peptide e fa'aosoina e ala fa'apitoa fa'apitoa nai lo le tele o le voluma. E ala i le ausia a 57.8% fetuunai tupe faasili i lana Life Science Group ma toe teu faafaigaluega 9.4% o tupe maua ile R&D, Ua fa'aalia e GenScript le malosi tau tamaoaiga o le fa'aogaina otometi ma le fa'aogaina o feso'ota'iga fa'afefiloi o auaunaga maualuga.
Mo CDMO peptide ogatotonu ma CROs, ua manino le faafanua:
-
Mata'ituina ma tausia le fa'aogaina o mea e mafai ona fa'aogaina i totonu o le 78% ia 85% sone.
-
Fa'alautele tomai fa'apitoa i suiga lavelave, lipidation, ma kemisi fa'ata'amilomilo e fa'aola lau Au'aunaga Mix Fa'asinomaga i luga 45%.
-
Teu faafaigaluega i Vasega 100 afifiina potu mama ma QA au'ili'ili e fa'amalieina tulaga fa'ata'atia mo biopharma mo sapalai fa'ata'ita'i ma falema'i.
Mo biopharma R&D tagata fai filifiliga, fa'apaleni fa'asoa fa'asoa i le va o kamupani tetele ma le tu'ufa'atasiga peptide CRO/CDMO fa'avae fa'amautinoa le saogalemu o sapalai fa'apisinisi mo taimi umi ma vave, maualuga-mama le tali atu mo le taua R&D paipa.

